LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®

Core Insights - LifeMD, Inc. has launched a limited-time introductory bundle for new self-pay patients, offering Wegovy at a discounted price of $199 along with access to its virtual weight management program for a total first-month cost of $299 [1][2] - The collaboration with Novo Nordisk enhances LifeMD's ability to provide branded GLP-1 medications through a fully integrated care experience, catering to the increasing number of self-pay patients seeking FDA-approved treatments [2][4] - The program will cost $599 per month starting from the second month, with no long-term commitment required [3] Company Overview - LifeMD is a leading provider of virtual primary care services, offering telemedicine, laboratory, and pharmacy services across more than 200 conditions, including weight management [6] - The company utilizes a vertically integrated platform, which includes a 50-state medical group and national diagnostic lab partnerships, to ensure a seamless experience from consultation to ongoing support [4][6] Product Offering - Wegovy is the first GLP-1 therapy approved in the U.S. for chronic weight management and cardiovascular risk reduction in adults with obesity, available in an injector pen by prescription for eligible LifeMD patients [5]